跳到正文
原文
FierceBiotech· @FierceBiotech · X·· 2026-10-16精选AI 评分58
AI 导读

OrbiMed 已为新生命科学投资募集 30 亿美元,其中包括规模超过 10 亿美元的亚洲基金,为其史上最大亚洲基金。该机构称,投资者对亚洲生物科技板块的兴趣持续上升。

推荐理由

OrbiMed 新募 30 亿美元并设规模最大的亚洲基金,反映资本对该区域生物科技资产的配置意愿。

正文

OrbiMed has raised $3 billion for new life sciences investments, including more than $1 billion for its largest-ever Asia fund, as investor interest in the region's biotech sector continues to grow. https://www.fiercebiotech.com/biotech/orbimeds-largest-ever-asian-fund-contributes-3b-war-chest

来源:FierceBiotech · x.com